Meld Valuation / Venture NAV Tracker
FundsCompaniesMethodology
meldvaluation.com ↗

Venture NAV Tracker / Private company

Orchestra BioMed Holdings, Inc.

Medical Devices & Equipment
Headquarters—
Founded—
Last known round—
Reported valuation—

Security-class differences are disclosed on the affected rows; non-degenerate marks remain in the underlying-company comparison band. 3 rows are omitted from dispersion statistics under the degenerate-mark guard; each affected row states why.

Cross-fund comparison

Equity & warrant marks

One underlying-company band; one latest disclosed mark per fund and security.

FundFair valueSecurity / annotationsImplied price / shareMark age vs roundMethodology / filing
HTGCHercules Capital, Inc.$1.6MJun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.No valuation basis was disclosed for this position. This is an annotation only and does not exclude the mark from comparison statistics.Carried at warrant/option value (net of strike), not underlying share value — not comparable to share marks as filed.Omitted from statistics — Carried at warrant/option value (net of strike), not underlying share value — not comparable to share marks as filed.$4.31Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
HTGCHercules Capital, Inc.$281KJun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.Filed as warrant; the comparison band's majority class is equity.No valuation basis was disclosed for this position. This is an annotation only and does not exclude the mark from comparison statistics.Carried at warrant/option value (net of strike), not underlying share value — not comparable to share marks as filed.Omitted from statistics — Carried at warrant/option value (net of strike), not underlying share value — not comparable to share marks as filed.$1.67Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗

Cross-fund comparison

Debt investments

Included in the same underlying-company comparison band.

FundSecurity type / annotationsPrincipalFair valueFV / principalRateMaturityMark age vs roundNon-accrual
HTGCHercules Capital, Inc.senior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior SecuredFiled as senior secured loan; the comparison band's majority class is equity.No valuation basis was disclosed for this position. This is an annotation only and does not exclude the mark from comparison statistics.Omitted from statistics — security type is not an eligible fund-equity mark for dispersion.$15MJun 30, 2026 · source ↗$15.3MJun 30, 2026 · source ↗102.0%Jun 30, 2026 · source ↗Prime + 2.00%, Floor rate 9.50%, 6.35% Exit FeeJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗NoJun 30, 2026 · source ↗

Historical marks

Reported fair value by fund

Each bar is a disclosed position-quarter.

$15.3MHTGCJun 30, 2026 · source ↗$1.6MHTGCJun 30, 2026 · source ↗$281KHTGCJun 30, 2026 · source ↗
Figures are compiled from public filings.Read methodologyMELD Valuation